Results 151 to 160 of about 41,114 (259)
Migraine: Epidemiology, Risk Factors, Pathophysiology, and Treatment
MedComm, Volume 7, Issue 9, September 2026.Migraine is a highly prevalent, female‐predominant, and disabling brain disorder shaped by genetic susceptibility, hormonal influences, modifiable attack factors, and comorbidity‐related progression. This review integrates current evidence on migraine epidemiology, phase‐specific neurovascular and neuroglial mechanisms, including CGRP signaling and ...
Weiwei Lu +9 more
wiley +1 more source
Metabolic Syndrome: From Mechanisms to Therapeutic Interventions
MedComm, Volume 7, Issue 9, September 2026.A comprehensive overview of molecular mechanisms delves into the potential disease mechanisms of metabolic syndrome, including complex mechanisms such as insulin resistance, chronic low‐grade inflammation, oxidative stress, and epigenetic modifications, and how these mechanisms contribute to the development of metabolic syndrome. Here, the relationship
Mengyao Yan, Qian Xiang
wiley +1 more source
Irritable Bowel Syndrome: Manipulating the Endocannabinoid System as First-Line Treatment
Frontiers in Neuroscience, 2020 Viola Brugnatelli +3 more
doaj +1 more source
Microbiota Medicine Research, Volume 1, Issue 3, Page 91-106, September 2026.Gut microbiota signatures distinguish chronic constipated patients from healthy individuals, supporting noninvasive diagnostic potential. Despite challenges in identifying psychiatric‐related comorbidities, microbial alterations, particularly in neurotransmitter and inflammatory pathways, lay the groundwork for future companion diagnostics and ...
Hongyan Qi +7 more
wiley +1 more source
Circadian rhythms and chronotherapy in Alzheimer's disease: Mechanisms and therapeutic implications
Neuroprotection, Volume 4, Issue 3, Page 229-247, September 2026.Circadian dysregulation contributes to Alzheimer's disease through sleep disruption, clock‐gene dysfunction, neuroinflammation, impaired proteostasis, and metabolic imbalance. These alterations promote cognitive decline and disease progression, while circadian biomarkers and chronotherapeutic interventions offer opportunities for precision diagnosis ...
Bivek Singh +2 more
wiley +1 more source
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Autism Spectrum Disorder
Neuropsychopharmacology Reports, Volume 46, Issue 3, September 2026.A case series studying outcomes up to 18 months in autistic patients from the UK Medical Cannabis Registry. ABSTRACT Introduction Autism spectrum disorder (ASD) is a neurodevelopmental disorder associated with distressed behaviors and psychological challenges.
Arushika Aggarwal +17 more
wiley +1 more source
Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 3, September 2026.Abstract Cannabinoid products are increasingly used worldwide despite limited psychiatric evidence. This narrative review synthesizes preclinical and clinical evidence on cannabidiol (CBD), cannabinol (CBN), and tetrahydrocannabinol (THC) to clarify their distinct psychiatric profiles and discuss how current evidence may inform ongoing clinical and ...
Yasuhiro Kishi +2 more
wiley +1 more source
Endocannabinoid mediates excitatory synaptic function of β-Neurexins
Frontiers in Neuroscience, 2016 Hansen eWang
doaj +1 more source
Effects of bromelain on endocannabinoid system and oxidative stress in a rat model of endometriosis. [PDF]
Rev Assoc Med Bras (1992)Herguner I +4 more
europepmc +1 more source
Alcohol, Clinical and Experimental Research, Volume 50, Issue 9, September 2026.PAE creates a unique inflammatory signature in the mature adult brain with region‐specific changes in genes implicated in glial‐immune function. We report at least 60 differentially expressed genes in different brain regions due to PAE, many of which are associated with neuroimmune function.
Alissa N. Jones +6 more
wiley +1 more source